IE820810L - Pharmaceutical preparations for treatment of diabetes - Google Patents
Pharmaceutical preparations for treatment of diabetesInfo
- Publication number
- IE820810L IE820810L IE820810A IE81082A IE820810L IE 820810 L IE820810 L IE 820810L IE 820810 A IE820810 A IE 820810A IE 81082 A IE81082 A IE 81082A IE 820810 L IE820810 L IE 820810L
- Authority
- IE
- Ireland
- Prior art keywords
- diabetes
- treatment
- release component
- pharmaceutical preparations
- benfluorex hydrochloride
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- 229960001213 benfluorex hydrochloride Drugs 0.000 abstract 4
- CJAVTWRYCDNHSM-UHFFFAOYSA-N benzoic acid 2-[1-[3-(trifluoromethyl)phenyl]propan-2-ylamino]ethyl ester Chemical compound C=1C=CC=CC=1C(=O)OCCNC(C)CC1=CC=CC(C(F)(F)F)=C1 CJAVTWRYCDNHSM-UHFFFAOYSA-N 0.000 abstract 4
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000008298 dragée Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000007119 pathological manifestation Effects 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Pharmaceutical preparations e.g. tablets, dragees or capsules of prolonged effect for the treatment of pathological manifestations connected with diabetes, which contain benfluorex hydrochloride as active ingredient, e.g. the benfluorex hydrochloride may be included in a digestible hydrophobic matrix and then dispersed in compressible excipients forming a hydrophilic network and a pharmaceutical combination which comprises a rapid release component of benfluorex hydrochloride and slow release component of benfluorex hydrochloride, these are usually present together in the same formulation and the slow release component may be composed in the same way as a single-component preparation.
[GB2099299A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8106915A FR2502952A1 (en) | 1981-04-07 | 1981-04-07 | NEW BENFLUOREX HYDROCHLORIDE DRUG FOR THE TREATMENT OF DIABETES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE820810L true IE820810L (en) | 1982-10-07 |
| IE52959B1 IE52959B1 (en) | 1988-04-27 |
Family
ID=9257087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE810/82A IE52959B1 (en) | 1981-04-07 | 1982-04-06 | Pharmaceutical preparations for treatment of diabetes |
Country Status (12)
| Country | Link |
|---|---|
| AU (1) | AU551033B2 (en) |
| BE (1) | BE892781A (en) |
| CA (1) | CA1186997A (en) |
| CH (1) | CH653551A5 (en) |
| FR (1) | FR2502952A1 (en) |
| GB (1) | GB2099299B (en) |
| IE (1) | IE52959B1 (en) |
| IT (1) | IT1148161B (en) |
| LU (1) | LU84069A1 (en) |
| NZ (1) | NZ200248A (en) |
| PH (1) | PH17582A (en) |
| ZA (1) | ZA822176B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4793999A (en) * | 1987-03-27 | 1988-12-27 | Sheth Prabhakar R | Method of manufacturing an antihypertensive, diuretic and antihypokalemic pharmaceutical composition with polyethylene glycol |
| AU4369589A (en) * | 1988-10-27 | 1990-05-03 | Abbott Laboratories | Controlled-release delivery device, method for producing device, and method of using device |
| FR2684552B1 (en) * | 1991-12-06 | 1995-04-28 | Adir | USE OF D-FENFLURAMINE AND FENFLURAMINE DERIVATIVES IN THE TREATMENT OF HYPERTENSION IN INSULIN RESISTANT SUBJECTS. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3062720A (en) * | 1959-05-20 | 1962-11-06 | Philips Roxane | Sustained release pharmaceutical tablet |
| GB1175516A (en) * | 1966-04-15 | 1969-12-23 | Science Union & Cie | New Phenyl-Aminopropane Derivatives and Preparations Containing them |
-
1981
- 1981-04-07 FR FR8106915A patent/FR2502952A1/en active Granted
-
1982
- 1982-03-30 ZA ZA822176A patent/ZA822176B/en unknown
- 1982-03-31 CA CA000400086A patent/CA1186997A/en not_active Expired
- 1982-04-05 LU LU84069A patent/LU84069A1/en unknown
- 1982-04-06 IT IT48180/82A patent/IT1148161B/en active
- 1982-04-06 CH CH2125/82A patent/CH653551A5/en not_active IP Right Cessation
- 1982-04-06 BE BE0/207773A patent/BE892781A/en not_active IP Right Cessation
- 1982-04-06 GB GB8210194A patent/GB2099299B/en not_active Expired
- 1982-04-06 AU AU82387/82A patent/AU551033B2/en not_active Ceased
- 1982-04-06 IE IE810/82A patent/IE52959B1/en not_active IP Right Cessation
- 1982-04-06 PH PH27095A patent/PH17582A/en unknown
- 1982-04-06 NZ NZ200248A patent/NZ200248A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LU84069A1 (en) | 1983-04-13 |
| FR2502952B1 (en) | 1983-10-07 |
| CA1186997A (en) | 1985-05-14 |
| GB2099299B (en) | 1985-04-03 |
| GB2099299A (en) | 1982-12-08 |
| PH17582A (en) | 1984-10-02 |
| IE52959B1 (en) | 1988-04-27 |
| IT8248180A0 (en) | 1982-04-06 |
| NZ200248A (en) | 1985-08-30 |
| BE892781A (en) | 1982-10-06 |
| FR2502952A1 (en) | 1982-10-08 |
| CH653551A5 (en) | 1986-01-15 |
| IT1148161B (en) | 1986-11-26 |
| ZA822176B (en) | 1983-02-23 |
| AU551033B2 (en) | 1986-04-17 |
| AU8238782A (en) | 1982-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE871584L (en) | Sustained release capsule. | |
| CA2154424A1 (en) | 1-phenyl-3-dimethylaminopropane compounds having a pharmaceutical effect | |
| HUT61031A (en) | Process for producing chemically modified, stable haemoglobin substituting for non-immunogehic red blood cell, and pharmaceutical compositions comprising same as active ingredient | |
| WO1998004249A3 (en) | Tramadol multiple unit formulations | |
| EP0348808A3 (en) | Pharmaceutical formulations and process for preparing them | |
| AU3326289A (en) | Matrix for release of active ingredients | |
| MX27046A (en) | 5-ARILALQUIL-4-ALCOXY-2 (5H) -FURANONAS, INTERMEDIATE PRODUCTS AND PROCEDURE FOR ITS PREPARATION AS WELL AS ITS APPLICATION AS AN ACTIVE THERAPEUTIC SUBSTANCE. | |
| CA2290017A1 (en) | Method for producing orally administered, solid pharmaceutical products with controlled release of the active substance | |
| PT74703B (en) | Process for the preparation of pharmaceutical compositions for topical use which are penetrable through the skin and contain as an active ingredient amongst others (e)-n-methyl-6,6-dimethyl-n-(naphtylmethyl)-hept-2-en-4-inyl-1-amine | |
| CA2093666A1 (en) | Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation | |
| NO163670C (en) | DEVICE FOR AUTO ADMINISTRATION OF PHYSIOLOGICALLY ACTIVE SUBSTANCES, WITHOUT OVERDOSAGE PREVENTION. | |
| IE881916L (en) | Press-coated dihydropyridine tablets | |
| ATE23110T1 (en) | DIVISIBLE DELAYED-RELEASE TABLET AND METHOD OF MANUFACTURE THEREOF. | |
| CA2199679A1 (en) | Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active ingredients | |
| FR2618073B1 (en) | HYDROPHILIC MATRIX-TYPE TABLETS BASED ON SALBUTAMOL AND THEIR PREPARATION METHOD | |
| EP0389177A3 (en) | Pharmaceutical formulation | |
| IE791235L (en) | Acyl-derivatives of carnitine. | |
| AU7001487A (en) | Difluorohalomethoxyphenyl derivative and miticide comprising said derivative as active ingredient | |
| AU1950388A (en) | Pharmaceutical formulation ensuring the transdermal absorption of the active ingredient and process for preparing same | |
| BR9404225A (en) | Formulation of active substance, application, compositions, drugs and process for the preparation of formulations | |
| AU591046B2 (en) | Physiologically active agent for agricultural use | |
| IE820810L (en) | Pharmaceutical preparations for treatment of diabetes | |
| WO2001006982A3 (en) | Low-dose tablets and preparation method | |
| CA2071625A1 (en) | A pharmaceutical preparation containing a thrombolytically active substance | |
| HUT53891A (en) | Nematocide insecticide and acaricide comprising 5-substituted-3-arylisoxazole derivatives as active ingredient and process for producing the active ingredients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed |